Nivolumab versus Best Supportive Care after failure of Chemotherapy in Non-Small Cell Lung Cancer Patients with ECOG 3 or 4: A Propensity Matched Analysis.

Immunotherapy demonstrated superior survival outcomes and acceptable tolerability profile than BSC in NSCLC patients with PS >2.

Authors

Publication Details

Journal
Oncology
Published
2026-03-23
DOI
https://doi.org/10.1159/000551462
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nivolumab versus Best Supportive Care after failure of Chemotherapy in Non-Small Cell Lung Cancer Patients with ECOG 3 or 4: A Propensity Matched Analysis.

Geetika Arya, Vineela Surapaneni, Dhruva Chaudhry, Aman Ahuja et al.
Oncology
Cancer Immunotherapy and Biomarkers
article

Nivolumab versus Best Supportive Care after failure of Chemotherapy in Non-Small Cell Lung Cancer Patients with ECOG 3 or 4: A Propensity Matched Analysis.

Geetika Arya, Vineela Surapaneni, Dhruva Chaudhry, Aman Ahuja, Jahanvi Grover, Pawan Kumar Singh, Yogita Kumari
article en

Abstract

Immunotherapy demonstrated superior survival outcomes and acceptable tolerability profile than BSC in NSCLC patients with PS >2.

Oncology
No poverty, Good health and well-being
Openalex Percentile: Top 13%
Cancer Immunotherapy and Biomarkers
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nivolumab versus Best Supportive Care after failure of Chemotherapy in Non-Small Cell Lung Cancer Patients with ECOG 3 or 4: A Propensity Matched Analysis. — Geetika Arya, Vineela Surapaneni, et al. · Oncology (2026) | TGRS Research Map | TGRS